We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,066

Celltrion’s and Hospira’s Production of Infliximab Biosimilars Does Not Infringe Remicide-Related Patent
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • August 20 2018

In a 104-page ruling, U.S. District Judge Mark L. Wolf granted summary judgment in favor of Celltrion and Hospira, finding that a doctrine of


Caution: When time runs out in the U.S. on white collar criminal conduct, it may not be the end of the story
  • Greenberg Traurig LLP
  • USA
  • August 16 2018

The UK is copying the United States in a variety of respects regarding the development of its investigation and disposal of white collar and


Health Canada invites public comments on new post-market reporting regulations
  • Gowling WLG
  • USA, Canada
  • August 9 2018

The medical device industry in America and perceived shortcomings in the US Food and Drug Administration's ("FDA") approval process have recently come


Relevant Public, Not General Public, When Determining Availability of Printed Publication
  • Jones Day
  • USA
  • August 9 2018

On July 27, 2018, the Federal Circuit reversed the PTAB’s finding that Petitioner GoPro, Inc. failed to establish the public availability of an


Arbitration Class Waivers, Past Practice (not established) and Skirmishing Over Information Requests All Part of Recent NLRB Action
  • Proskauer Rose LLP
  • USA
  • August 8 2018

Since December 2017, when the Board issued a number of decisions which restored precedent that had been changed in the last few years, (discussed here


New USCIS ‘Deportation’ Policy May Impact Legal Foreign Workers
  • Dickinson Wright
  • USA
  • August 7 2018

On July 5, 2018, U.S. Citizenship and Immigration Services (USCIS) published new guidance dated June 28, 2018 regarding when officers should issue a


Federal Circuit Splits Hairs in Hair Removal Product Interference Proceeding
  • Marshall Gerstein & Borun LLP
  • USA
  • August 7 2018

In General Hospital Corp. v. Sienna Biopharmaceuticals, Inc., Case No. 2017-1012 (Fed. Cir. May 4, 2018), the Federal Circuit affirmed the PTAB’s


Using Theses as Prior Art at the PTAB
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • August 7 2018

Based on recent Patent Trial and Appeal Board (“PTAB” or “the Board”) decisions, the best practice to establish an academic thesis as a printed


Domestic violence leave is here (for some)
  • MARQUE Lawyers
  • Australia
  • August 6 2018

Each week at least one woman is murdered, and there are at least two reported victims, as a result of family and domestic violence (FDV) related


Redacting Sensitive But Not Privileged Information: Surveying the Cases For and Against - PART ONE
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • August 6 2018

We have previously written about the perils of redacting non-responsive but sensitive material during pre-trial discovery in the context of a